chr3-49422261-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The ENST00000273588.9(AMT):​c.101G>A​(p.Arg34His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000622 in 1,614,046 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R34C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00055 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 3 hom. )

Consequence

AMT
ENST00000273588.9 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.312
Variant links:
Genes affected
AMT (HGNC:473): (aminomethyltransferase) This gene encodes one of four critical components of the glycine cleavage system. Mutations in this gene have been associated with glycine encephalopathy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009922236).
BP6
Variant 3-49422261-C-T is Benign according to our data. Variant chr3-49422261-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 531783.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Likely_benign=1, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AMTNM_000481.4 linkuse as main transcriptc.101G>A p.Arg34His missense_variant 2/9 ENST00000273588.9 NP_000472.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AMTENST00000273588.9 linkuse as main transcriptc.101G>A p.Arg34His missense_variant 2/91 NM_000481.4 ENSP00000273588 P1P48728-1

Frequencies

GnomAD3 genomes
AF:
0.000545
AC:
83
AN:
152222
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.000804
AC:
202
AN:
251204
Hom.:
0
AF XY:
0.000803
AC XY:
109
AN XY:
135816
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00834
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000564
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000629
AC:
920
AN:
1461706
Hom.:
3
Cov.:
31
AF XY:
0.000619
AC XY:
450
AN XY:
727158
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.00139
Gnomad4 ASJ exome
AF:
0.00677
Gnomad4 EAS exome
AF:
0.000630
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000517
Gnomad4 OTH exome
AF:
0.000894
GnomAD4 genome
AF:
0.000551
AC:
84
AN:
152340
Hom.:
1
Cov.:
32
AF XY:
0.000618
AC XY:
46
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.000192
Gnomad4 AMR
AF:
0.00144
Gnomad4 ASJ
AF:
0.00547
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.000913
Hom.:
1
Bravo
AF:
0.000767
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000692
AC:
84
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Non-ketotic hyperglycinemia Uncertain:1Benign:2
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Dec 16, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 10, 2023Variant summary: AMT c.101G>A (p.Arg34His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00063 in 1461706 control chromosomes, predominantly at a frequency of 0.0026 within the Middle Eastern subpopulation in the gnomAD database, and it is present in three homozygotes across all subpopulations. The observed variant frequency is 1.86-fold of the estimated maximal expected allele frequency for a pathogenic variant in AMT causing Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) (0.0026 vs. 0.0014), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Middle Eastern origin. To our knowledge, no occurrence of c.101G>A in individuals affected with Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) and no experimental evidence demonstrating its impact on protein function have been reported. Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One classified the variant as uncertain significance, and two classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
AMT-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 08, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.76
D;T;.;.;T;T;.;T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.42
N
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0099
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
1.9
L;.;L;L;.;.;.;.
MutationTaster
Benign
0.92
D;D;D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-2.3
N;.;N;N;.;.;.;.
REVEL
Benign
0.24
Sift
Benign
0.034
D;.;D;D;.;.;.;.
Sift4G
Benign
0.086
T;.;T;T;.;.;.;.
Polyphen
0.043
B;.;.;.;.;.;.;.
Vest4
0.31
MVP
0.89
MPC
0.26
ClinPred
0.031
T
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.21
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138259479; hg19: chr3-49459694; API